NINDS announces its intent to issue Funding Opportunity Announcements to support analytical validation of identified candidate biomarkers.
NINDS has renewed an initiative to provide set-aside funds for basic research grants that miss their regular payline.
NIH announces intent to reissue a Funding Opportunity Announcement for the Rare Disease Clinical Research Network competition.
Increased skin cancer risks in DM1 are captured in a new, longitudinal electronic medical records study.
A recent publication suggests that a serum protein may ultimately have value as a biomarker for conduction system abnormalities in DM.
MDF is deeply saddened to report the passing of Andrew B. Linbeck, a devoted and passionate supporter of the Foundation who promoted Care for people living with DM. Andrew passed away on November 8th, 2017 in Houston, Texas.
The Myotonic Dystrophy Foundation is pleased to announce that the U.S. Senate has, for the first time ever, included myotonic dystrophy as part of the Department of Defense’s premier biomedical research program – the Peer-Reviewed Medical Research Program.
- 1 of 33
- next ›